German scientists came up with the discovery of a new biomarker which could be controlled to assess a response to chemotherapy of colorectal cancer. Indication of methylation of transcription factor AP-2 epsilon (TFAP2E) gens can be useful medical examination, helping to determine a chemotherapy resistance. (1,2) Read full text »

For the first time British scientists managed to prove that low doses of acetylsalicylic acid (ASA) are able to reduce the risk of colorectal cancer (CRC) incidence. It means that the daily dose of 75mg ASA could be safely introduced into CRC chemoprophylaxis, at the same time minimising the risks of side effects associated with chronic intake of higher doses. Read full text »